Glomerular Disease in Patients with Acute and Chronic Infections
By:
Meghan E. Sise Department of Nephrology, Massachusetts General Hospital, Boston, Massachusetts

Search for other papers by Meghan E. Sise in
Current site
Google Scholar
PubMed Close
Volume/Issue:
Volume 19: Issue 2
Published Online:
Oct 2020
Restricted access
Purchase Print On-Demand ASN Members Sign In Here
  • Collapse
  • Expand

Volume 19: Issue 2 (Oct 2020): Primary and Secondary Glomerular Diseases

in Nephrology Self-Assessment Program
Cover Nephrology Self-Assessment Program
Copyright:
© American Society of Nephrology 2020
Page Count:
11
Article Category:
Research Article
Print Publication Date:
01 Oct 2020
Published Online:
Oct 2020
  • 1.

    AIDS JUNPoHa. AIDS Info 2018. Available at: https://aidsinfo.unaids.org/. Accessed March 20, 2020

    • PubMed
    • Export Citation
  • 2.

    Mocroft A , Lundgren JD , Ross M , Fux CA , Reiss P , Moranne O , et al.; Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study: Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: A prospective international cohort study. Lancet HIV 3: e23–e32, 2016 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Guaraldi G , Malagoli A , Calcagno A , Mussi C , Celesia BM , Carli F , et al.: The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: A cross sectional study of people aged 65-74 years and more than 75 years. BMC Geriatr 18: 99, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Mocroft A , Lundgren JD , Ross M , Law M , Reiss P , Kirk O , et al.; D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group: Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med 12: e1001809, 2015 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Swanepoel CR , Atta MG , D’Agati VD , Estrella MM , Fogo AB , Naicker S , et al.; Conference Participants: Kidney disease in the setting of HIV infection: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int 93: 545–559, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Rao TK , Filippone EJ , Nicastri AD , Landesman SH , Frank E , Chen CK , et al.: Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 310: 669–673, 1984 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Sise ME , Lo GC , Goldstein RH , Allegretti AS , Masia R : Case 12-2017 - A 34-year-old man with nephropathy. N Engl J Med 376: 1575–1585, 2017 PubMed

  • 8.

    Winston JA , Bruggeman LA , Ross MD , Jacobson J , Ross L , D’Agati VD , et al.: Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 344: 1979–1984, 2001 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Levin ML , Palella F , Shah S , Lerma E , Butter J , Kanwar YS : HIV-associated nephropathy occurring before HIV antibody seroconversion. Am J Kidney Dis 37: E39, 2001 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Cohen AH , Nast CC : HIV-associated nephropathy: A unique combined glomerular, tubular, and interstitial lesion. Mod Pathol 1: 87–97, 1988 PubMed

  • 11.

    D’Agati V , Suh JI , Carbone L , Cheng JT , Appel G : Pathology of HIV-associated nephropathy: A detailed morphologic and comparative study. Kidney Int 35: 1358–1370, 1989 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12.

    Bruggeman LA , Dikman S , Meng C , Quaggin SE , Coffman TM , Klotman PE : Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 100: 84–92, 1997 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13.

    Kopp JB , Nelson GW , Sampath K , Johnson RC , Genovese G , An P , et al.: APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 22: 2129–2137, 2011 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14.

    Papeta N , Kiryluk K , Patel A , Sterken R , Kacak N , Snyder HJ , et al.: APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. J Am Soc Nephrol 22: 1991–1996, 2011 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15.

    Atta MG , Estrella MM , Skorecki KL , Kopp JB , Winkler CA , Wasser WG , et al.: Association of APOL1 genotype with renal histology among black HIV-positive patients undergoing kidney biopsy. Clin J Am Soc Nephrol 11: 262–270, 2016 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16.

    Kasembeli AN , Duarte R , Ramsay M , Mosiane P , Dickens C , Dix-Peek T , et al.: APOL1 risk variants are strongly associated with HIV-associated nephropathy in black South Africans. J Am Soc Nephrol 26: 2882–2890, 2015 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17.

    Fine DM , Wasser WG , Estrella MM , Atta MG , Kuperman M , Shemer R , et al.: APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease. J Am Soc Nephrol 23: 343–350, 2012 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18.

    Estrella MM , Li M , Tin A , Abraham AG , Shlipak MG , Penugonda S , et al.: The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status. Clin Infect Dis 60: 646–652, 2015 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19.

    Atta MG , Estrella MM , Kuperman M , Foy MC , Fine DM , Racusen LC , et al.: HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics. Kidney Int 82: 338–343, 2012 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20.

    Mallipattu SK , Salem F , Wyatt CM : The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy. Kidney Int 86: 259–265, 2014 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21.

    Lucas GM , Eustace JA , Sozio S , Mentari EK , Appiah KA , Moore RD : Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: A 12-year cohort study. AIDS 18: 541–546, 2004 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22.

    Lescure FX , Flateau C , Pacanowski J , Brocheriou I , Rondeau E , Girard PM , et al.: HIV-associated kidney glomerular diseases: Changes with time and HAART. Nephrol Dial Transplant 27: 2349–2355, 2012 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23.

    Berliner AR , Fine DM , Lucas GM , Rahman MH , Racusen LC , Scheel PJ , et al.: Observations on a cohort of HIV-infected patients undergoing native renal biopsy. Am J Nephrol 28: 478–486, 2008 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24.

    Koech MK , Owiti MOG , Owino-Ong’or WD , Koskei AK , Karoney MJ , D’Agati VD , et al.: Absence of HIV-associated nephropathy among antiretroviral naive adults with persistent albuminuria in western Kenya. Kidney Int Rep 2: 159–164, 2016 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25.

    Kudose S , Santoriello D , Bomback AS , Stokes MB , Batal I , Markowitz GS , et al.: The spectrum of kidney biopsy findings in HIV-infected patients in the modern era. Kidney Int 97: 1006–1016, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26.

    Lucas GM , Ross MJ , Stock PG , Shlipak MG , Wyatt CM , Gupta SK , et al.; HIV Medicine Association of the Infectious Diseases Society of America: Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 59: e96–e138, 2014 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27.

    Atta MG , Gallant JE , Rahman MH , Nagajothi N , Racusen LC , Scheel PJ , et al.: Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol Dial Transplant 21: 2809–2813, 2006 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28.

    Burns GC , Paul SK , Toth IR , Sivak SL : Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy. J Am Soc Nephrol 8: 1140–1146, 1997 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29.

    Post FA , Campbell LJ , Hamzah L , Collins L , Jones R , Siwani R , et al.: Predictors of renal outcome in HIV-associated nephropathy. Clin Infect Dis 46: 1282–1289, 2008 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30.

    Bigé N , Lanternier F , Viard JP , Kamgang P , Daugas E , Elie C , et al.: Presentation of HIV-associated nephropathy and outcome in HAART-treated patients. Nephrol Dial Transplant 27: 1114–1121, 2012 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31.

    Razzak Chaudhary S , Workeneh BT , Montez-Rath ME , Zolopa AR , Klotman PE , Winkelmayer WC : Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy. Nephrol Dial Transplant 30: 1734–1740, 2015 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32.

    Boyle SM , Lee DH , Wyatt CM : HIV in the dialysis population: Current issues and future directions. Semin Dial 30: 430–437, 2017 PubMed

  • 33.

    Sawinski D , Forde KA , Locke JE , Cohen JB , Weldon J , Shults J , et al.: Race but not hepatitis C co-infection affects survival of HIV+ individuals on dialysis in contemporary practice. Kidney Int 93: 706–715, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34.

    Stock PG , Barin B , Murphy B , Hanto D , Diego JM , Light J , et al.: Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med 363: 2004–2014, 2010 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35.

    Locke JE , Mehta S , Reed RD , MacLennan P , Massie A , Nellore A , et al.: A national study of outcomes among HIV-infected kidney transplant recipients. J Am Soc Nephrol 26: 2222–2229, 2015 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36.

    Waheed S , Sakr A , Chheda ND , Lucas GM , Estrella M , Fine DM , et al.: Outcomes of renal transplantation in HIV-1 associated nephropathy. PLoS One 10: e0129702, 2015 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37.

    Locke JE , Gustafson S , Mehta S , Reed RD , Shelton B , MacLennan PA , et al.: Survival benefit of kidney transplantation in HIV-infected patients. Ann Surg 265: 604–608, 2017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38.

    Muller E , Barday Z , Mendelson M , Kahn D : HIV-positive-to-HIV-positive kidney transplantation: Results at 3 to 5 years. N Engl J Med 372: 613–620, 2015 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39.

    Haas M , Kaul S , Eustace JA : HIV-associated immune complex glomerulonephritis with “lupus-like” features: A clinicopathologic study of 14 cases. Kidney Int 67: 1381–1390, 2005 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 40.

    Foy MC , Estrella MM , Lucas GM , Tahir F , Fine DM , Moore RD , et al.: Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy. Clin J Am Soc Nephrol 8: 1524–1532, 2013 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 41.

    Global Hepatitis Report 2017. Geneva: World Health Organization 2017. Available at: https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/. Accessed March 20, 2020

    • PubMed
    • Export Citation
  • 42.

    Viral Hepatitis Surveillance - United States, 2017. Centers for Disease Control and Prevention; 2017 November 14, 2019. Available at: https://www.cdc.gov/hepatitis/statistics/2017surveillance/index.htm. Accessed March 20, 2020

    • PubMed
    • Export Citation
  • 43.

    Ferri C , Zignego AL , Pileri SA : Cryoglobulins. J Clin Pathol 55: 4–13, 2002 PubMed

  • 44.

    Cicardi M , Cesana B , Del Ninno E , Pappalardo E , Silini E , Agostoni A , et al.: Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C. J Viral Hepat 7: 138–143, 2000 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 45.

    Rutledge SM , Chung RT , Sise ME : Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis. Hemodial Int 22[Suppl 1]: S81–S96, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 46.

    D’Amico G , Colasanti G , Ferrario F , Sinico RA : Renal involvement in essential mixed cryoglobulinemia. Kidney Int 35: 1004–1014, 1989 PubMed

  • 47.

    Trejo O , Ramos-Casals M , García-Carrasco M , Yagüe J , Jiménez S , de la Red G , et al.: Cryoglobulinemia: Study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) 80: 252–262, 2001 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 48.

    Pouteil-Noble C , Maiza H , Dijoud F , MacGregor B : Glomerular disease associated with hepatitis C virus infection in native kidneys. Nephrol Dial Transplant 15[Suppl 8]: 28–33, 2000 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 49.

    Sinico RA , Winearls CG , Sabadini E , Fornasieri A , Castiglione A , D’Amico G : Identification of glomerular immune deposits in cryoglobulinemia glomerulonephritis. Kidney Int 34: 109–116, 1988 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 50.

    D’Amico G : Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis. Kidney Int 54: 650–671, 1998 PubMed

  • 51.

    De Vita S , Quartuccio L , Isola M , Mazzaro C , Scaini P , Lenzi M , et al.: A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum 64: 843–853, 2012 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 52.

    Sneller MC , Hu Z , Langford CA : A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis. Arthritis Rheum 64: 835–842, 2012 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 53.

    Kidney Disease: Improving Global Outcomes (CKD-MBD) Update Work Group : KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD. Kidney Int Suppl (2011) 7: 1–59, 2017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 54.

    Saadoun D , Pol S , Ferfar Y , Alric L , Hezode C , Si Ahmed SN , et al..: Efficacy and safety of sofosbuvir plus daclatasvir for treatment of HCV-associated cryoglobulinemia vasculitis. Gastroenterology. 2017;153(1):49-52 e5

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 55.

    Emery JS , Kuczynski M , La D , Almarzooqi S , Kowgier M , Shah H , et al.: Efficacy and safety of direct acting antivirals for the treatment of mixed cryoglobulinemia. Am J Gastroenterol 112: 1298–1308, 2017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 56.

    Jadoul M , Berenguer MC , Doss W , Fabrizi F , Izopet J , Jha V , et al.: Executive summary of the 2018 KDIGO hepatitis C in CKD guideline: Welcoming advances in evaluation and management. Kidney Int 94: 663–673, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 57.

    Kidney Disease: Improving Global Outcomes (KDIGO): KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int Suppl Apr: S1–S99, 2008 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 58.

    Johnson RJ , Gretch DR , Yamabe H , Hart J , Bacchi CE , Hartwell P , et al.: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328: 465–470, 1993 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 59.

    Misiani R , Bellavita P , Fenili D , Vicari O , Marchesi D , Sironi PL , et al.: Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330: 751–756, 1994 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 60.

    Casato M , Agnello V , Pucillo LP , Knight GB , Leoni M , Del Vecchio S , et al.: Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection. Blood 90: 3865–3873, 1997 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 61.

    Mazzaro C , Zorat F , Caizzi M , Donada C , Di Gennaro G , Maso LD , et al.: Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: A pilot study. J Hepatol 42: 632–638, 2005 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 62.

    Hadziyannis SJ , Sette H Jr , Morgan TR , Balan V , Diago M , Marcellin P , et al.; PEGASYS International Study Group: Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose. Ann Intern Med 140: 346–355, 2004 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 63.

    Cacoub P , Lidove O , Maisonobe T , Duhaut P , Thibault V , Ghillani P , et al.: Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 46: 3317–3326, 2002 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 64.

    Dammacco F , Tucci FA , Lauletta G , Gatti P , De Re V , Conteduca V , et al.: Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: A long-term study. Blood 116: 343–353, 2010 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 65.

    Quartuccio L , Soardo G , Romano G , Zaja F , Scott CA , De Marchi G , et al.: Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: Efficacy and safety in the absence of steroids. Rheumatology (Oxford) 45: 842–846, 2006 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 66.

    Roccatello D , Baldovino S , Rossi D , Mansouri M , Naretto C , Gennaro M , et al.: Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Nephrol Dial Transplant 19: 3054–3061, 2004 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 67.

    Zaja F , Vianelli N , Sperotto A , Patriarca F , Tani M , Marin L , et al.: Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases. Leuk Lymphoma 44: 1951–1955, 2003 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 68.

    Sansonno D , De Re V , Lauletta G , Tucci FA , Boiocchi M , Dammacco F : Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood 101: 3818–3826, 2003 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 69.

    Saadoun D , Resche-Rigon M , Sene D , Perard L , Karras A , Cacoub P : Rituximab combined with peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis. Ann Rheum Dis 67: 1431–1436, 2008 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 70.

    Cacoub P , Delluc A , Saadoun D , Landau DA , Sene D : Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: Where do we stand? Ann Rheum Dis 67: 283–287, 2008 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 71.

    Saadoun D , Resche Rigon M , Sene D , Terrier B , Karras A , Perard L , et al.: Rituximab plus peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia. Blood 116: 326–334, quiz 504–505, 2010 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 72.

    Bonacci M , Lens S , Marino Z , Londono MC , Rodriguez-Tajes S , Sanchez-Tapias JM , et al..: Long-term outcomes of patients with HCV-associated cryoglobulinemic vasculitis after virologic cure. Gastroenterology 155: 311–315, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 73.

    Gragnani L , Piluso A , Urraro T , Fabbrizzi A , Fognani E , Petraccia L , et al.: Virological and clinical response to interferon-free regimens in patients with HCV-related mixed cryoglobulinemia: Preliminary results of a prospective pilot study. Curr Drug Targets 18: 772–785, 2017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 74.

    Saadoun D , Thibault V , Si Ahmed SN , Alric L , Mallet M , Guillaud C , et al.: Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study. Ann Rheum Dis 75: 1777–1782, 2016 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 75.

    Comarmond C , Garrido M , Pol S , Desbois AC , Costopoulos M , Le Garff-Tavernier M , et al.: Direct-acting antiviral therapy restores immune tolerance to patients with hepatitis C virus-induced cryoglobulinemia vasculitis. Gastroenterology 152: 2052–2062, 2017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 76.

    Gragnani L , Visentini M , Fognani E , Urraro T , De Santis A , Petraccia L , et al.: Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia. Hepatology 64: 1473–1482, 2016 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 77.

    Sise ME , Bloom AK , Wisocky J , Lin MV , Gustafson JL , Lundquist AL , et al.: Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents. Hepatology 63: 408–417, 2016 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 78.

    Sollima S , Milazzo L , Peri AM , Torre A , Antinori S , Galli M : Persistent mixed cryoglobulinaemia vasculitis despite hepatitis C virus eradication after interferon-free antiviral therapy. Rheumatology (Oxford) 55: 2084–2085, 2016 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 79.

    Mauro E , Quartuccio L , Ghersetti M , Lenzi M , Gitto S , Andreone P , et al.: Direct acting antiviral (DAA) therapy of HCV, effects on the cryoglobulinemic vasculitis: A multicenter open label study. Dig Liver Dis 49: E32, 2017

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 80.

    Cerretelli G , Gragnani L , Monti M , Arena U , Fognani E , Petraccia L , et al.: Sofosbuvir/ribavirin treatment in patients with genotype 2, hepatitis C virus infection and symptomatic mixed cryoglobulinemia: An interim analysis on safety, efficacy and impact on quality of life. J Hepatol 66: S505, 2017

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 81.

    Diakite M , Hartig-Lavie K , Miailhes P , Pradat P , Uhres AC , Zoulim F , et al.: Benefit of direct-acting antiviral therapy in hepatitis C virus (HCV) monoinfected and HIV-HCV coinfected patients with mixed cryoglobulinemia. J Hepatol 66: S528–S529, 2017

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 82.

    Bonacci M , Lens S , Londono MC , Marino Z , Cid MC , Ramos-Casals M , et al.: Virologic, clinical, and immune response outcomes of patients with hepatitis C virus-associated cryoglobulinemia treated with direct-acting antivirals. Clin Gastroenterol Hepatol 15: 575–583, 2017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 83.

    Roth D , Nelson DR , Bruchfeld A , Liapakis A , Silva M , Monsour H Jr , et al.: Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): A combination phase 3 study. Lancet 386: 1537–1545, 2015 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 84.

    Gane E , Lawitz E , Pugatch D , Papatheodoridis G , Bräu N , Brown A , et al.: Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment. N Engl J Med 377: 1448–1455, 2017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 85.

    Lawitz E , Flisiak R , Abunimeh M , Sise ME , Park JY , Kaskas M , et al.: Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection. Liver Int 40: 1032–1041, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 86.

    Borgia SM , Dearden J , Yoshida EM , Shafran SD , Brown A , Ben-Ari Z , et al.: Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis. J Hepatol 71: 660–665, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 87.

    Roth D , Bloom RD , Molnar MZ , Reese PP , Sawinski D , Sise ME , et al.: KDOQI US commentary on the 2018 KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C. Am J Kidney Dis 75: 665–683, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 88.

    Barbieri D , García-Prieto A , Torres E , Verde E , Goicoechea M , Luño J : Mixed cryoglobulinaemia vasculitis after sustained hepatitis C virological response with direct-acting antivirals. Clin Kidney J 12: 362–364, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 89.

    Fayed A , El Nokeety MM , Samy Abdelaziz T , Samir HH , Hamza WM , El Shabony T : Incidence and characteristics of de novo renal cryoglobulinemia after direct-acting antivirals treatment in an Egyptian hepatitis C cohort. Nephron 140: 275–281, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 90.

    Sise ME , Wisocky J , Rosales IA , Chute D , Holmes JA , Corapi KM , et al.: Lupus-like immune complex-mediated glomerulonephritis in patients with hepatitis C virus infection treated with oral, interferon-free, direct-acting antiviral therapy. Kidney Int Rep 1: 135–143, 2016 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 91.

    Hogan JJ , Lim MA , Palmer MB , Bloom RD , Chung RT , Sise ME : Development of proteinuria and focal segmental glomerulosclerosis during direct-acting antiviral therapy for hepatitis C virus infection. Hepatology 66: 658–660, 2017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 92.

    Ghosn M , Palmer MB , Najem CE , Haddad D , Merkel PA , Hogan JJ . New-onset hepatitis C virus-associated glomerulonephritis following sustained virologic response with direct-acting antiviral therapy. Clin Nephrol 87: 261–266, 2017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 93.

    Kupin WL : Viral-associated GN: Hepatitis C and HIV. Clin J Am Soc Nephrol 12: 1337–1342, 2017 PubMed

  • 94.

    Stehman-Breen C , Alpers CE , Couser WG , Willson R , Johnson RJ : Hepatitis C virus associated membranous glomerulonephritis. Clin Nephrol 44: 141–147, 1995 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 95.

    Markowitz GS , Cheng JT , Colvin RB , Trebbin WM , D’Agati VD : Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol 9: 2244–2252, 1998 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 96.

    Coroneos E , Truong L , Olivero J : Fibrillary glomerulonephritis associated with hepatitis C viral infection. Am J Kidney Dis 29: 132–135, 1997 PubMed

  • 97.

    Nasr SH , Valeri AM , Cornell LD , Fidler ME , Sethi S , Leung N , et al.: Fibrillary glomerulonephritis: A report of 66 cases from a single institution. Clin J Am Soc Nephrol 6: 775–784, 2011 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 98.

    Matsumoto S , Nakajima S , Nakamura K , Etani Y , Hirai H , Shimizu N , et al.: Interferon treatment on glomerulonephritis associated with hepatitis C virus. Pediatr Nephrol 15: 271–273, 2000 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 99.

    Ji F , Li Z , Ge H , Deng H : Successful interferon-α treatment in a patient with IgA nephropathy associated with hepatitis C virus infection. Intern Med 49: 2531–2532, 2010 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 100.

    You CR , Lee SW , Jang JW , Yoon SK : Update on hepatitis B virus infection. World J Gastroenterol 20: 13293–13305, 2014 PubMed

  • 101.

    Sunbul M : Hepatitis B virus genotypes: Global distribution and clinical importance. World J Gastroenterol 20: 5427–5434, 2014 PubMed

  • 102.

    Combes B , Shorey J , Barrera A , Stastny P , Eigenbrodt EH , Hull AR , et al.: Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet 2: 234–237, 1971 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 103.

    Lai KN , Li PK , Lui SF , Au TC , Tam JS , Tong KL , et al.: Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 324: 1457–1463, 1991 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 104.

    Xie Q , Li Y , Xue J , Xiong Z , Wang L , Sun Z , et al.: Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy. Am J Nephrol 41: 345–353, 2015 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 105.

    Moon JY , Lee SH : Treatment of hepatitis B virus-associated membranous nephropathy: Lamivudine era versus post-lamivudine era. Korean J Intern Med (Korean Assoc Intern Med) 27: 394–396, 2012 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 106.

    Conjeevaram HS , Hoofnagle JH , Austin HA , Park Y , Fried MW , Di Bisceglie AM : Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa. Gastroenterology 109: 540–546, 1995 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 107.

    Lin CY : Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon. Kidney Int 47: 225–230, 1995 PubMed

  • 108.

    Chung DR , Yang WS , Kim SB , Yu E , Chung YH , Lee Y , et al.: Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon. Am J Nephrol 17: 112–117, 1997 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 109.

    Tang S , Lai FM , Lui YH , Tang CS , Kung NN , Ho YW , et al.: Lamivudine in hepatitis B-associated membranous nephropathy. Kidney Int 68: 1750–1758, 2005 PubMed

  • 110.

    Khedmat H , Taheri S : Hepatitis B virus-associated nephropathy: An international data analysis. Iran J Kidney Dis 4: 101–105, 2010 PubMed

  • 111.

    Fabrizi F , Dixit V , Martin P : Meta-analysis: Anti-viral therapy of hepatitis B virus-associated glomerulonephritis. Aliment Pharmacol Ther 24: 781–788, 2006 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 112.

    Chang TT , Gish RG , de Man R , Gadano A , Sollano J , Chao YC , et al.; BEHoLD AI463022 Study Group: A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med 354: 1001–1010, 2006 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 113.

    Wang L , Ye Z , Liang H , Zhang B , Xu L , Feng Z , et al.: The combination of tacrolimus and entecavir improves the remission of HBV-associated glomerulonephritis without enhancing viral replication. Am J Transl Res 8: 1593–1600, 2016 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 114.

    Lai KN , Tam JS , Lin HJ , Lai FM : The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia. Nephron 54: 12–17, 1990 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 115.

    Taskapan H , Oymak O , Dogukan A , Ozbakir O , Utas C : Transformation of hepatitis B virus-related membranous glomerulonephritis to crescentic form. Clin Nephrol 54: 161–163, 2000 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 116.

    Lai FM , Tam JS , Li PK , Lai KN : Replication of hepatitis B virus with corticosteroid therapy in hepatitis B virus related membranous nephropathy. Virchows Arch A Pathol Anat Histopathol 414: 279–284, 1989 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 117.

    Michalak T : Immune complexes of hepatitis B surface antigen in the pathogenesis of periarteritis nodosa: A study of seven necropsy cases. Am J Pathol 90: 619–632, 1978 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 118.

    Guillevin L : Infections in vasculitis. Best Pract Res Clin Rheumatol 27: 19–31, 2013 PubMed

  • 119.

    Lai KN , Lai FM : Clinical features and the natural course of hepatitis B virus-related glomerulopathy in adults. Kidney Int Suppl 35: S40–S45, 1991 PubMed

  • 120.

    Trepo C , Thivolet J : Hepatitis associated antigen and periarteritis nodosa (PAN). Vox Sang 19: 410–411, 1970 PubMed

  • 121.

    Heermann KH , Gerlich WH : Immunology of hepatitis B virus infections. Rheumatol Int 9: 167–173, 1989 PubMed

  • 122.

    Trepo C , Guillevin L : Polyarteritis nodosa and extrahepatic manifestations of HBV infection: The case against autoimmune intervention in pathogenesis. J Autoimmun 16: 269–274, 2001 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 123.

    Levin S , Graber J , Ehrenwald E , Skeik N : Polyarteritis nodosa-induced pancreaticoduodenal artery aneurysmal rupture. Int J Angiol 24: 63–66, 2015 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 124.

    Guillevin L , Lhote F , Cohen P , Sauvaget F , Jarrousse B , Lortholary O , et al.: Polyarteritis nodosa related to hepatitis B virus: A prospective study with long-term observation of 41 patients. Medicine (Baltimore) 74: 238–253, 1995 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 125.

    Hernández-Rodríguez J , Alba MA , Prieto-González S , Cid MC : Diagnosis and classification of polyarteritis nodosa. J Autoimmun 48-49: 84–89, 2014 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 126.

    Pagnoux C , Seror R , Henegar C , Mahr A , Cohen P , Le Guern V , et al.; French Vasculitis Study Group: Clinical features and outcomes in 348 patients with polyarteritis nodosa: A systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 62: 616–626, 2010 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 127.

    Guillevin L , Mahr A , Callard P , Godmer P , Pagnoux C , Leray E , et al.; French Vasculitis Study Group: Hepatitis B virus-associated polyarteritis nodosa: Clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 84: 313–322, 2005 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 128.

    De Virgilio A , Greco A , Magliulo G , Gallo A , Ruoppolo G , Conte M , et al.: Polyarteritis nodosa: A contemporary overview. Autoimmun Rev 15: 564–570, 2016 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 129.

    Segelmark M , Selga D : The challenge of managing patients with polyarteritis nodosa. Curr Opin Rheumatol 19: 33–38, 2007 PubMed

  • 130.

    Mukhtyar C , Guillevin L , Cid MC , Dasgupta B , de Groot K , Gross W , et al.; European Vasculitis Study Group: EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68: 310–317, 2009 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 131.

    Sun IO , Hong YA , Park HS , Choi SR , Chung BH , Park CW , et al.: Clinical characteristics and treatment of patients with IgA nephropathy and hepatitis B surface antigen. Ren Fail 35: 446–451, 2013 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 132.

    Zhou TB , Jiang ZP : Is there an association of hepatitis B virus infection with minimal change disease of nephrotic syndrome? A clinical observational report. Ren Fail 37: 459–461, 2015 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 133.

    Cheng Y , Luo R , Wang K , Zhang M , Wang Z , Dong L , et al.: Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 97: 829–838, 2020

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 134.

    Nasr SH , Markowitz GS , Stokes MB , Said SM , Valeri AM , D’Agati VD : Acute postinfectious glomerulonephritis in the modern era: Experience with 86 adults and review of the literature. Medicine (Baltimore) 87: 21–32, 2008 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 135.

    Sharmin S , Shimizu Y , Hagiwara M , Hirayama K , Koyama A : Staphylococcus aureus antigens induce IgA-type glomerulonephritis in Balb/c mice. J Nephrol 17: 504–511, 2004 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 136.

    Shimizu Y , Sakurai H , Hirayama K , Seki M , Yoh K , Yamagata K , et al.: Staphylococcal cell membrane antigen, a possible antigen in post-methicillin resistant Staphylococcus aureus (MRSA) infection nephritis and IgA nephropathy, exhibits high immunogenic activity that is enhanced by superantigen. J Nephrol 18: 249–256, 2005 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 137.

    Satoskar AA , Molenda M , Scipio P , Shim R , Zirwas M , Variath RS , et al.: Henoch-Schönlein purpura-like presentation in IgA-dominant Staphylococcus infection-associated glomerulonephritis: A diagnostic pitfall. Clin Nephrol 79: 302–312, 2013 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 138.

    Nasr SH , Fidler ME , Valeri AM , Cornell LD , Sethi S , Zoller A , et al.: Postinfectious glomerulonephritis in the elderly. J Am Soc Nephrol 22: 187–195, 2011 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 139.

    Satoskar AA , Suleiman S , Ayoub I , Hemminger J , Parikh S , Brodsky SV , et al.: Staphylococcus infection-associated GN: Spectrum of IgA staining and prevalence of ANCA in a single-center cohort. Clin J Am Soc Nephrol 12: 39–49, 2017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 140.

    Montseny JJ , Meyrier A , Kleinknecht D , Callard P : The current spectrum of infectious glomerulonephritis: Experience with 76 patients and review of the literature. Medicine (Baltimore) 74: 63–73, 1995 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 141.

    Batsford SR , Mezzano S , Mihatsch M , Schiltz E , Rodríguez-Iturbe B : Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH? Kidney Int 68: 1120–1129, 2005 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 142.

    Rodríguez-Iturbe B , Batsford S : Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet. Kidney Int 71: 1094–1104, 2007 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 143.

    Rodriguez-Iturbe B , Musser JM : The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol 19: 1855–1864, 2008 PubMed

  • 144.

    Eison TM , Ault BH , Jones DP , Chesney RW , Wyatt RJ : Post-streptococcal acute glomerulonephritis in children: Clinical features and pathogenesis. Pediatr Nephrol 26: 165–180, 2011 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 145.

    Lien JW , Mathew TH , Meadows R : Acute post-streptococcal glomerulonephritis in adults: A long-term study. Q J Med 48: 99–111, 1979 PubMed

  • 146.

    Sorger K , Balun J , Hübner FK , Köhler H , Olbing H , Schulz W , et al.: The garland type of acute postinfectious glomerulonephritis: Morphological characteristics and follow-up studies. Clin Nephrol 20: 17–26, 1983 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 147.

    Sorger K , Gessler M , Hübner FK , Köhler H , Olbing H , Schulz W , et al.: Follow-up studies of three subtypes of acute postinfectious glomerulonephritis ascertained by renal biopsy. Clin Nephrol 27: 111–124, 1987 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 148.

    Tejani A , Ingulli E : Poststreptococcal glomerulonephritis: Current clinical and pathologic concepts. Nephron 55: 1–5, 1990 PubMed

  • 149.

    Fries JW , Mendrick DL , Rennke HG : Determinants of immune complex-mediated glomerulonephritis. Kidney Int 34: 333–345, 1988 PubMed

  • 150.

    Dagan R , Cleper R , Davidovits M , Sinai-Trieman L , Krause I : Post-infectious glomerulonephritis in pediatric patients over two decades: Severity-associated features. Isr Med Assoc J 18: 336–340, 2016 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 151.

    Wyatt RJ , Forristal J , West CD , Sugimoto S , Curd JG : Complement profiles in acute post-streptococcal glomerulonephritis. Pediatr Nephrol 2: 219–223, 1988 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 152.

    Johnston F , Carapetis J , Patel MS , Wallace T , Spillane P : Evaluating the use of penicillin to control outbreaks of acute poststreptococcal glomerulonephritis. Pediatr Infect Dis J 18: 327–332, 1999 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 153.

    Pickering MC , D’Agati VD , Nester CM , Smith RJ , Haas M , Appel GB , et al.: C3 glomerulopathy: Consensus report. Kidney Int 84: 1079–1089, 2013 PubMed

  • 154.

    Brodsky SV , Nadasdy T , Cassol, C , Satoskar, A : IgA staining patterns differentiate between IgA nephropathy and IgA-dominant infection-associated glomerulonephritis, Kidney Int Rep 5: 909–911, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 155.

    Sethi S , Fervenza FC , Zhang Y , Zand L , Meyer NC , Borsa N , et al.: Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement. Kidney Int 83: 293–299, 2013 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 156.

    Chauvet S , Berthaud R , Devriese M , Mignotet M , Vieira Martins P , Robe-Rybkine T , et al.: Anti-factor B antibodies and acute postinfectious GN in children. J Am Soc Nephrol 31: 829–840, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 157.

    Moroni G , Pozzi C , Quaglini S , Segagni S , Banfi G , Baroli A , et al.: Long-term prognosis of diffuse proliferative glomerulonephritis associated with infection in adults. Nephrol Dial Transplant 17: 1204–1211, 2002 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 158.

    Gamble CN , Reardan JB : Immunopathogenesis of syphilitic glomerulonephritis: Elution of antitreponemal antibody from glomerular immune-complex deposits. N Engl J Med 292: 449–454, 1975 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 159.

    Hoshino-Shimizu S , De Brito T , Kanamura HY , Canto AL , Silva AO , Campos AR , et al.: Human schistosomiasis: Schistosoma mansoni antigen detection in renal glomeruli. Trans R Soc Trop Med Hyg 70: 492–496, 1976 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 160.

    Houba V : Experimental renal disease due to schistosomiasis. Kidney Int 16: 30–43, 1979 PubMed

  • 161.

    Silva GBD , Pinto JR , Barros EJG , Farias GMN , Daher EF : Kidney involvement in malaria: An update. Rev Inst Med Trop São Paulo 59: e53, 2017 PubMed

  • 162.

    Gelman R , Brook G , Green J , Ben-Itzhak O , Nakhoul F : Minimal change glomerulonephritis associated with hydatid disease. Clin Nephrol 53: 152–155, 2000 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 163.

    Ali-Khan Z , Rausch RL : Demonstration of amyloid and immune complex deposits in renal and hepatic parenchyma of Alaskan alveolar hydatid disease patients. Ann Trop Med Parasitol 81: 381–392, 1987 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 199 137 53
Full Text Views 183 65 7
PDF Downloads 227 77 10